1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. BEAM THERAPEUTICS INC
Beam Therapeutics Inc
XNAS: BEAM
25.26 0.31 (1.24%)
1.7M
XNAS Volume

XNAS 21 Sep, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Beam Therapeutics Inc - BEAM - stock price prediction, stock price target, analyst ratings from 15 analysts

Beam Therapeutics Inc has a share price target of US$ 52, revenue growth forecast of -65.2%, and profit growth estimate of -477.4% for FY26, based on top 15 analyst calls.